Live·Verified funding discovery · 2026.2
874 grants · 19 open · 435 companies · 2640 concepts874 / 19 / 435 / 2640
COMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CACOMPANIESCompanies rated · 435 (no change)PROJECTSProjects rated · 70 (no change)CATALOGUE874 grants in catalogue · 19 open right nowPOWERED BYOpen Longevity · 501(c)(3) · Sherman Oaks, CA
← Back to Eternal Search

Corentine M. C. Laurin

individual
Ecosystem influencer

About

Corentine M. C. Laurin is a medicinal chemist and Senior Principal Scientist in Chemistry at General Proximity, where she leads chemistry efforts for novel therapeutics. She completed a PhD at the University of Oxford on bromodomain inhibitors and later did postdoctoral work at Yale in Craig Crews' lab on proximity-inducing drug modalities including PROTACs and molecular glues. Her background also includes research experience with Hoffmann-La Roche and GlaxoSmithKline.

Areas of interest

biotechmedicinal chemistrydrug discoverychemical biologytargeted protein degradationPROTACsmolecular gluesepigeneticstherapeutics